Allergy Skin Testing
JJ · Effective Oct 1, 2015
55 active Medicare policies list J44.0, and 14 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
14 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of J44.0 |
|---|---|---|
| Analysis of Volatile Organic Compounds | Oct 3, 2023 | Covered |
| Chest Physiotherapy and Airway Clearance Devices | Mar 17, 2023 | Covered |
| Electrical Stimulation for Nausea, Vomiting, Motion Sickness and Other Selected Indications | Jan 5, 2024 | Covered |
| Enhanced External Counterpulsation (EECP) | Jun 7, 2023 | Covered |
| Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries | Sep 13, 2023 | Covered |
| Lung Denervation Therapy and Lung Volume Reduction Surgery |
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J9 · Effective Jul 11, 2021
JK · Effective Dec 1, 2021
JH · Effective Jul 11, 2021
JL · Effective Jul 11, 2021
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
National · Effective Oct 1, 2025
National · Effective Feb 15, 2026
J6 · Effective Nov 7, 2019
National · Effective Mar 5, 2026
National · Effective Oct 1, 2025
National · Effective Nov 6, 2025
National · Effective Jan 1, 2026
National · Effective Mar 19, 2026
National · Effective Mar 19, 2026
National · Effective Apr 16, 2026
J5 · Effective Mar 12, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
J6 · Effective Feb 19, 2026
National · Effective Oct 23, 2025
National · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
National · Effective Nov 6, 2025
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Jul 31, 2025
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Feb 1, 2026
| Mar 16, 2023 |
| Covered |
| Phonophoresis | Apr 11, 2023 | Covered |
|---|
| Polymerase Chain Reaction Testing: Selected Indications | Feb 9, 2024 | Covered |
|---|
| Varicella and Herpes Zoster Vaccines | Mar 22, 2023 | Covered |
|---|
| Policy | Effective | Status of J44.0 |
|---|---|---|
| Gamma Glutamyl Transferase Testing | Jul 1, 2026 | Covered |
| Mechanical Insufflation-Exsufflation Devices | Jul 1, 2026 | Covered |
| Noninvasive Home Ventilator Therapy for Respiratory Failure | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J44.0 |
|---|---|---|
| Polymerase Chain Reaction Respiratory Viral Panel Testing | Not recorded | Covered |
| Pulmonary Function Testing | Not recorded | Covered |